Which of the following is a recommendation from PSI regarding screening for PMADs?

Screening for Perinatal Mood and Anxiety Disorders (PMADs) is a crucial component in promoting maternal mental health and well-being. The recommendation to screen at the first prenatal visit and at subsequent visits is founded on the understanding that mental health issues can arise during pregnancy and the postpartum period, as well as the fact that early identification and intervention can significantly improve outcomes for both the mother and the infant.

By initiating screening during the first prenatal visit, healthcare providers can establish a baseline for the mother's mental health, allowing them to monitor for any changes as the pregnancy progresses and postnatally. Regular screenings during subsequent visits ensure that any emerging symptoms are detected promptly, which facilitates timely access to support and treatment. This comprehensive approach is vital in recognizing that PMADs can occur at any point in the perinatal period, not solely in postpartum stages.

This strategy aligns with evidence-based practices recommended by organizations such as Postpartum Support International (PSI), emphasizing that mental health should be a continual focus throughout the perinatal experience.